CSF protein tests to predict shunt response in hydrocephalus
Part of Brain & nervous system, Mental health clinical trials.
This study looks at fluid-based “CSF” protein markers to predict how well a brain shunt works in adults with chronic hydrocephalus (fluid buildup). If you qualify, your CSF sample may help doctors better estimate your likely response to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a diagnosis consistent with chronic adult hydrocephalus (not just a temporary or unclear cause)
- Be able to undergo the planned CSF testing related to the study
- Not have another brain cause that would explain symptoms instead of chronic adult hydrocephalus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who may have normal-pressure hydrocephalus (fluid-related swelling in the brain) and also focuses on sleep apnea. It may help researchers understand whether treating or studying sleep issues could improve symptoms related to this condition.
This study looks at older adults with normal pressure hydrocephalus (a buildup of fluid in the brain) to see if certain tests, like a spinal tap, can predict who will benefit from a shunt (a tube that drains extra fluid). This could help patients and doctors decide together whether surgery is a good option.
This study looks at proteins in the fluid around the brain and spinal cord (cerebrospinal fluid) to learn more about neurological conditions. Samples are collected during routine procedures, and leftover fluid is studied to find markers that may help diagnose or track these conditions.
This study tests a new wireless device that measures fluid flow in a CSF shunt (a tube that drains fluid from the brain). You may join if you have a shunt under your skin across your collarbone and can use or be nearby the device for a month.
This trial is testing a wearable thermal device that checks if your CSF shunt is working properly. It may help understand if your headaches are linked to shunt problems. The study involves using the device at home for 30 days and going to a few follow-up visits.
This study checks how well a device called ShuntCheck works for monitoring a ventriculoperitoneal (VP) shunt in people who feel okay (no symptoms) with normal pressure hydrocephalus. It may help improve future shunt checks during routine care.
Hear when a new Beta-amiloid and Phospho-tau Proteins in CSF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.